Autoimmune lymphoproliferative syndrome: Difference between revisions
No edit summary |
|||
(One intermediate revision by the same user not shown) | |||
Line 18: | Line 18: | ||
{{Autoimmune lymphoproliferative syndrome}} | {{Autoimmune lymphoproliferative syndrome}} | ||
'''Editor-In-Chief:''' David Teachey, MD [mailto:TEACHEYD@email.chop.edu] | '''Editor-In-Chief:''' David Teachey, MD [mailto:TEACHEYD@email.chop.edu] '''Associate editor in chief''': {{SharmiB}} | ||
{{SK}} Canale-Smith syndrome; ALPS | {{SK}} Canale-Smith syndrome; ALPS |
Latest revision as of 04:06, 3 August 2021
Autoimmune lymphoproliferative syndrome | |
OMIM | 601859 603909 |
---|---|
DiseasesDB | 33425 Template:DiseasesDB2 |
Autoimmune lymphoproliferative syndrome Microchapters |
Differentiating Autoimmune lymphoproliferative syndrome from other Diseases |
---|
Diagnosis |
Treatment |
Case Studies |
Autoimmune lymphoproliferative syndrome On the Web |
American Roentgen Ray Society Images of Autoimmune lymphoproliferative syndrome |
Directions to Hospitals Treating Autoimmune lymphoproliferative syndrome |
Risk calculators and risk factors for Autoimmune lymphoproliferative syndrome |
Editor-In-Chief: David Teachey, MD [1] Associate editor in chief: Sharmi Biswas, M.B.B.S
Synonyms and keywords: Canale-Smith syndrome; ALPS
Overview
Historical Perspective
Classification
Pathophysiology
Causes
Differentiating Autoimmune lymphoproliferative syndrome from other Diseases
Epidemiology and Demographics
Risk Factors
Screening
Natural History, Complications and Prognosis
References
Diagnosis
Diagnostic Criteria | History and Symptoms | Physical Examination | Laboratory Findings | Electrocardiogram | Chest X Ray | CT | MRI | Echocardiography or Ultrasound | Other Imaging Findings | Other Diagnostic Studies
Treatment
Medical Therapy | Surgery | Primary Prevention | Secondary Prevention | Cost-Effectiveness of Therapy | Future or Investigational Therapies